Skip to content

Robert W. Eitches

NPI 1043256316ActiveIndividual· Allergy & Immunology, Allergy· Los Angeles, CA

Opted out of Medicare from October 2015 to October 2027. Allergy & Immunology, Allergy in Los Angeles, California, licensed in CA, with an NPI issued in June 2006. Part D covered 511 prescriptions written in 2024, 73% of them generic. Glaxosmithkline, LLC. was the largest of 14 companies reporting payments in 2025, $1,200 in all, mostly food and beverage.

Overview

NPI1043256316
StatusActive
Entity typeIndividual
Sole proprietorNo
NPI issuedJun 22, 2006
Last updated in NPPESNov 14, 2008

Specialties and licenses

TaxonomyCodeLicenseState
Allergy & Immunology, Allergy Primary207KA0200XG44618CA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026
Opt-outOpted out Oct 1, 2015 – Oct 1, 2027
Can order and referYes

During an opt-out period the provider sees Medicare patients only under private contracts, and Medicare does not pay claims for their services.

Part D prescriptions in 2024

Prescriptions (claims)511 · 727 30-day fills
Patients91
Total drug cost$69,612
Generic share73% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$1,200 · 54 payments from 14 companies
  • 2024$883.65 · 36 payments from 11 companies

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$1,200 · 54 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Allergy & Immunology, Allergy providers in Los Angeles

All Allergy & Immunology, Allergy providers in California →